tru Independence’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$477K Buy
398
+5
+1% +$5.11K 0.21% 55
2026
Q1
$362K Buy
393
+17
+5% +$17.2K 0.18% 68
2025
Q4
$404K Buy
376
+25
+7% +$23.9K 0.1% 92
2025
Q3
$268K Sell
351
-6
-2% -$4.46K 0.07% 113
2025
Q2
$278K Buy
357
+6
+2% +$4.66K 0.08% 107
2025
Q1
$290K Buy
351
+3
+0.9% +$2.5K 0.09% 99
2024
Q4
$268K Sell
348
-2
-0.6% -$1.66K 0.08% 100
2024
Q3
$310K Buy
350
+28
+9% +$25.2K 0.09% 95
2024
Q2
$292K Buy
322
+63
+24% +$50.4K 0.09% 93
2024
Q1
$201K Buy
+259
New +$184K 0.06% 108
2021
Q2
Sell
-2,231
Closed -$416K 327
2021
Q1
$416K Buy
2,231
+2,111
+1,759% +$413K 0.08% 184
2020
Q4
$20 Buy
120
+55
+85% +$8.21K ﹤0.01% 540
2020
Q3
$10K Sell
65
-43
-40% -$6.66K ﹤0.01% 280
2020
Q2
$18K Buy
108
+1
+0.9% +$153 ﹤0.01% 518
2020
Q1
$15K Hold
107
﹤0.01% 402
2019
Q4
$15K Buy
+107
New +$12.4K ﹤0.01% 517

Other funds holding LLY

tru Independence's LLY Position: Q2 2026 in Review

tru Independence increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $5.11K and bringing the position to 398 shares worth $477K. The position accounts for 0.21% of the portfolio, ranked #55.

tru Independence first reported a position in LLY in Q4 2019 and has held it in 16 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • tru Independence held 398 shares of Eli Lilly worth $477K as of Q2 2026.
  • tru Independence bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.21% of tru Independence's portfolio in Q2 2026, its #55 holding.
  • tru Independence first reported a position in Eli Lilly in Q4 2019 and has held it in 16 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on tru Independence's 13F filing for Q2 2026, filed 10 Aug 2026.